<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Transpl. Int.</journal-id>
<journal-title-group>
<journal-title>Transplant International</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Transpl. Int.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1432-2277</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">15860</article-id>
<article-id pub-id-type="doi">10.3389/ti.2025.15860</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Hidden in Plain Sight: High Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality</article-title>
<alt-title alt-title-type="left-running-head">S&#xfc;sal et al.</alt-title>
<alt-title alt-title-type="right-running-head">Tacrolimus CDR and Kidney Outcomes</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>S&#xfc;sal</surname>
<given-names>Caner</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/699966"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>D&#xf6;hler</surname>
<given-names>Bernd</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/402749"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Demir</surname>
<given-names>Erol</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ibrahim</surname>
<given-names>Walaa</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Askar</surname>
<given-names>Medhat</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Institute of Immunology, Heidelberg University Hospital</institution>, <city>Heidelberg</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Transplant Immunology Research Center of Excellence TIREX, Ko&#xe7; University School of Medicine</institution>, <city>Istanbul</city>, <country country="TR">T&#xfc;rkiye</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Division of Nephrology, Department of Internal Medicine, Yeditepe University School of Medicine</institution>, <city>Istanbul</city>, <country country="TR">T&#xfc;rkiye</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Department of Internal Medicine and Nephrology, Faculty of Medicine, Assiut University</institution>, <city>Assiut</city>, <country country="EG">Egypt</country>
</aff>
<aff id="aff5">
<label>5</label>
<institution>Health Sector and Department of Immunology, College of Medicine, Qatar University</institution>, <city>Doha</city>, <country country="QA">Qatar</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Caner S&#xfc;sal, <email xlink:href="mailto:csusal@ku.edu.tr">csusal@ku.edu.tr</email>; Medhat Askar, <email xlink:href="mailto:maskar@qu.edu.qa">maskar@qu.edu.qa</email>
</corresp>
<fn fn-type="other" id="fn001">
<label>&#x2020;</label>
<p>ORCID: Caner S&#xfc;sal, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-2521-8201">orcid.org/0000-0003-2521-8201</ext-link>; Bernd D&#xf6;hler, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-0051-096X">orcid.org/0000-0003-0051-096X</ext-link>; Erol Demir, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-0128-5645">orcid.org/0000-0003-0128-5645</ext-link>; Walaa Ibrahim, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-3217-0544">orcid.org/0000-0002-3217-0544</ext-link>; Medhat Askar, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-2633-9363">orcid.org/0000-0003-2633-9363</ext-link>
</p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-17">
<day>17</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>38</volume>
<elocation-id>15860</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>06</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 S&#xfc;sal, D&#xf6;hler, Demir, Ibrahim and Askar.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>S&#xfc;sal, D&#xf6;hler, Demir, Ibrahim and Askar</copyright-holder>
<license>
<ali:license_ref start_date="2025-12-17">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Transpl. Int." journal-id-type="nlm-ta" xlink:href="10.3389/ti.2025.15207" ext-link-type="doi">A Corrigendum on <article-title>Hidden in Plain Sight: High Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality</article-title> by S&#xfc;sal C, D&#xf6;hler B, Demir E, Ibrahim W and Askar M (2025). Transpl. Int. 38:15207. doi: <object-id>10.3389/ti.2025.15207</object-id>
</related-article>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<graphic xlink:href="TI_ti-2025-15860_wc_abs.tif" position="anchor">
<alt-text content-type="machine-generated">High tacrolimus metabolism is linked to increased kidney transplant failure and infection-related mortality. The study analyzed 21,865 kidney transplants from 2000 to 2019, the largest to date. About 25.2% had a low concentration-dose-ratio (CDR), predicting poor outcomes with a hazard ratio up to 2.80 and a 63% increase in infection-related mortality. Higher risk groups include females, young individuals, and those with CYP3A5*1A. Strategies like diltiazem co-medication and steroid tapering may improve long-term outcomes in patients with low CDR. Conducted by Caner S&#xFC;sal, published in Transplant International.</alt-text>
</graphic>
</fig>
</p>
</abstract>
<kwd-group>
<kwd>kidney transplant</kwd>
<kwd>tacrolimus concentration-to-dose ratio</kwd>
<kwd>allograft loss</kwd>
<kwd>mortality</kwd>
<kwd>infection</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
</counts>
</article-meta>
</front>
<body>
<p>In the published article, there was an error in the article title. Instead of &#x201c;<italic>Hidden in Plain Sight: Low Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality</italic>&#x201d;, it should be &#x201c;<italic>Hidden in Plain Sight: High Tacrolimus Metabolism Doubles Kidney Transplant Failure and Drives Infection Related Mortality</italic>&#x201d;.</p>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
<sec sec-type="ai-statement" id="s1">
<title>Generative AI statement</title>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
</body>
</article>